Notice of ceasing to be substantial holder 2024 Announcements . Financial . News . Regulatory 01.08.2024
Appendix 3H – Notification of cessation of securities 2024 Announcements . Financial . News . Regulatory 05.07.2024
Afamelanotide assists DNA repair response following UV radiation 2024 Announcements . Clinical . News 05.07.2024
CLINUVEL extends Managing Director’s Employment Agreement 2024 Announcements . Corporate . News 28.06.2024
SCENESSE® European Orphan Drug Designation for Variegate Porphyria 2024 Announcements . Clinical . News 24.06.2024
Technical note: Afamelanotide as MC1R-targeted therapy in Parkinson’s [PD] 2024 Announcements . Clinical . News 18.06.2024
CLINUVEL withdraws SCENESSE® label expansion for adolescent erythropoietic protoporphyria 2024 Announcements . Clinical . News 03.06.2024